News Related to Pacific Research Institute

Related coverage linked through entity extraction aliases.

FDA Proposes Limits on Compounding for GLP-1 Drugs as Safety Fears Grow

Jul 22, 2026

The FDA proposes to remove three GLP-1 drugs from the bulk compounding list as adverse events near 2,000 and Senator Tom Cotton demands a probe into Chinese APIs in compounded meds. Shortages have largely resolved, but safety and innovation concerns persist.

TrumpRx Drug Prices Fall Short of UK Costs for Many Medicines

Mar 19, 2026

Analysis shows around a third of 54 drugs on TrumpRx.gov are cheaper in the UK, while the platform offers significant savings primarily for obesity and fertility drugs not typically covered by insurance.